<DOC>
	<DOCNO>NCT00162916</DOCNO>
	<brief_summary>The purpose study explore extent continue antidepressant medication citalopram ( Celexa ) , depression respond treatment , help prevent return depressive symptom patient recent traumatic brain injury ( TBI ) .</brief_summary>
	<brief_title>Antidepressant Maintenance Traumatic Brain Injury</brief_title>
	<detailed_description>While antidepressant effective treat major depression follow TBI , lack certainty long antidepressant must continue follow improvement symptom . Many study publish last decade strongly show antidepressant prevent relapse patient major depression absence traumatic brain injury ( TBI ) . However , unknown whether case follow TBI . The aim study determine whether antidepressant year reduces risk relapse depression . Patients diagnose major depression follow mild TBI treat ten week antidepressant drug citalopram . Those respond , mean symptom depression lessen significantly , randomly assign either continue take citalopram one year take placebo one year . Every four week , additional forty week , patient assess relapse depression . This study double-blind design , mean neither patient clinician know whether citalopram placebo administer . The primary outcome interest comparison percentage patient recurrence major depression continue citalopram compare switch placebo acute phase . Recurrence define meet Diagnostic Statistical Manual Mental Disorders , 4th Edition ( DSM-IV ) criterion major depression Hamilton Depression Scale ( HAM-D ) score &gt; 16 . Or meet DSM-IV criterion major depression Clinical Global Impression ( CGI ) severity score &gt; = 4 CGI illness score &gt; = 3 . The HAM-D CGI administer every four week forty week .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Age &gt; 18 year TBI within last year ( consistent clinic population ) Mild TBI Written , inform consent Diagnosis major depressive episode use depression module Structured Clinical Interview DSMIV Axis I disorder ( SCIDIV ) , baseline 17item Hamilton Depression ( HAMD ) Rating Scale score 16 ( prior selective serotonin reuptake inhibitor [ SSRI ] treatment ) Response citalopram 20 40mg/d , define reduction baseline HAMD &gt; = 50 % , HAMD score 10 ; response citalopram define meeting DSMIV criterion major depression Clinical Global Impression severity mildly ill , borderline ill , normal Clinical Global Impression improvement much improve much improve impression . Prior TBI focal brain disease ( e.g. , stroke , tumour ) Significant acute medical illness include : drug overdose ; severely disturb liver , kidney , lung heart function ; anemia ; hypothyroidism ; uncontrolled diabetes ; Parkinson 's disease ; Huntington 's chorea ; progressive supranuclear palsy ; brain tumor ; subdural hematoma ; multiple sclerosis . Current alcohol substance abuse A brain computed tomographic ( CT ) scan reveal focal lesion could interpret consistent TBI Presence premorbid psychiatric diagnosis schizophrenia , dementia bipolar disorder Prior episode major depression two year prior TBI , base SCIDIV interview Prior treatment citalopram contraindication receive treatment citalopram</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Traumatic Brain Injury</keyword>
	<keyword>Depression</keyword>
	<keyword>Antidepressant medication</keyword>
	<keyword>Double-Blind Study</keyword>
	<keyword>Brain Injuries</keyword>
	<keyword>Antidepressive Agents</keyword>
	<keyword>Citalopram</keyword>
	<keyword>Double-Blind Method</keyword>
</DOC>